News

New interactive tool provides free access to real-world ALS data

The ALS Association has launched the ALS Focus Data Dashboard, a free interactive tool that gives researchers, clinicians, and the public access to five years of self-reported clinical, demographic, and socioeconomic data from more than 4,000 people with amyotrophic lateral sclerosis (ALS) and their caregivers across the U.S.

Insitro, Bristol Myers extend research into new drug for ALS

Bristol Myers Squibb is extending a research collaboration with the artificial intelligence company Insitro to design new medicines against a novel target in amyotrophic lateral sclerosis (ALS). The target was identified during the previous five-year agreement between the companies, which aimed to discover new molecules that could…

Diabetes adds greater risk of mobility loss in ALS: Study

People with amyotrophic lateral sclerosis (ALS) who also have diabetes tend to lose the ability to walk faster than non-diabetic patients, according to a study from Japan. The findings underscore the importance of supportive mobility care for diabetic ALS patients, scientists said in the study, “Factors…

AI model helps predict ALS mortality using clinical metrics

Using seven clinical measures that are fairly easy to assess, researchers have developed a machine learning model to help predict mortality in people with amyotrophic lateral sclerosis (ALS), according to a study. The model, which was trained on data from more than 1,900 patients, may aid clinicians and families…